title: Erythropoietin treatment for anemia in end-stage renal disease with diabetes mellitus.
authors: K
authors: K
authors: Nakatsuka
authors: M
authors: M
authors: Hino
authors: T
authors: T
authors: Miki
authors: Y
authors: Y
authors: Nishizawa
authors: T
authors: T
authors: Tabata
authors: T
authors: T
authors: Inoue
authors: H
authors: H
authors: Morii
mesh_terms: D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D003928:Diabetic Nephropathies / Q000097:blood / Q000628:therapy*; D004921:Erythropoietin / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006400:Hematocrit; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D006435:Renal Dialysis / Q000009:adverse effects*
chemical_list: D004921:Erythropoietin; D006442:Glycated Hemoglobin; D011994:Recombinant Proteins